title: Light induced changes in quinolone levels in rat serum and tissues.
abstract: Circadian rhythm may induce alterations of the pharmacokinetic properties of several drugs in clinical use. The aim of the study was to investigate whether lighting conditions alter the quinolone (pefloxacin) levels in serum and tissues and to determine any accumulation of the drug in the skin. Thirty male Wistar rats were divided into groups A, B, C, (n=10). The animals of group A were housed under 12h light/12h dark conditions, group B under 24h UV and group C was kept in complete darkness. All animals received 5 doses of 11mg/Kg pefloxacin every 8h for 48h.Pefloxacin levels were determined in serum, skin and femur by the inhibition zone in E.coli. in vitro. Pefloxacin concentrations in serum were increased in 24h darkness living status and decreased in 24h UV conditions as compared to group A animals. Additionally, both skin and femur pefloxacin levels were decreased under dark and UV conditions. In conclusion total light as well as total dark exposure may lead to pefloxacin pharmacokinetic changes which may have implications in the effectiveness of the drug in tissues.
authors.affiliation: Department of pharmacology, School of Medicine, University of Athens, Greece.
authors.forename: C
authors.initials: C
authors.lastname: Tesseromatis
authors.forename: A
authors.initials: A
authors.lastname: Kotsiou
authors.forename: C
authors.initials: C
authors.lastname: Mourouzis
authors.forename: Th
authors.initials: T
authors.lastname: Saranteas
authors.forename: A
authors.initials: A
authors.lastname: Potamianou
authors.forename: E
authors.initials: E
authors.lastname: Vairactaris
mesh_terms: D000818:Animals; D002940:Circadian Rhythm / Q000502:physiology*; D005269:Femur / Q000378:metabolism*; D008029:Lighting; D008297:Male; D015363:Quinolones / Q000097:blood* / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D012867:Skin / Q000378:metabolism*; D014018:Tissue Distribution / Q000502:physiology
chemical_list: D015363:Quinolones
references.citation: Life Sci Space Res. 1970;8:240-6
references.pmid: 11826885
references.citation: J Invest Dermatol. 2003 Jul;121(1):165-71
references.pmid: 12839577
references.citation: Photochem Photobiol. 2003 Mar;77(3):259-64
references.pmid: 12685652
references.citation: Psychoneuroendocrinology. 2003 Feb;28(2):207-27
references.pmid: 12510013
references.citation: Int J Cancer. 1994 Nov 15;59(4):543-7
references.pmid: 7960225
references.citation: J Photochem Photobiol B. 1992 May 15;13(3-4):275-88
references.pmid: 1506992
references.citation: Stress. 2003 Jun;6(2):127-32
references.pmid: 12775332
references.citation: Drug Saf. 2003;26(2):109-20
references.pmid: 12534327
references.citation: Neuroreport. 2004 Feb 9;15(2):313-6
references.pmid: 15076759
references.citation: Clin Pediatr (Phila). 2004 Jan-Feb;43(1):63-8
references.pmid: 14968894
references.citation: J Neural Transm Gen Sect. 1993;92(1):25-32
references.pmid: 8329170
references.citation: Biochim Biophys Acta. 1975 Aug 25;398(2):315-24
references.pmid: 1237316
references.citation: Br J Dermatol. 2003 Dec;149(6):1232-41
references.pmid: 14674902
references.citation: J Biol Rhythms. 2002 Oct;17(5):438-46
references.pmid: 12375620
references.citation: Eur J Drug Metab Pharmacokinet. 1996 Jul-Sep;21(3):213-5
references.pmid: 8980917
references.citation: Cell Biochem Funct. 2001 Mar;19(1):37-41
references.pmid: 11223869
references.citation: Proc Nutr Soc. 2003 Aug;62(3):753-60
references.pmid: 14692611
references.citation: J Pharmacol Exp Ther. 1990 Nov;255(2):672-9
references.pmid: 2243347
references.citation: Chronobiol Int. 1996 Jul;13(2):113-21
references.pmid: 8877120